Skip to main content
. 2009 Jan 8;9:1. doi: 10.1186/1756-6649-9-1

Table 3.

Toxicities by grade and causality in the newly diagnosed GBM patients treated with combined TTFields-Temozolomide.

Grade Causality assessment
I-II III-IV

Elevated LFTs 6/10 0/10 Anti Epileptic Drugs
Hyperglycemia 4/10 0/10 Oral Steroids
Anemia 6/10 0/10 Temozolomide
Thrombocytopenia 2/10 0/10 Temozolomide
Leucopenia 3/10 0/10 Temozolomide
Headache 2/10 0/10 Underlying disease
Seizures 1/10 0/10 Underlying disease
Dermatitis 10/10 0/10 NovoTTF-100A